Gloom about the performanceofmicrobicidegels aimed at preventing HIVinfection lifted a little yesterday (9 February) withthe results of amajor newtrial.
This BMC Infectious Diseases paper cited by Wolf showed that mice instilled with various vaginal gels containing microbicide experienced greater herpes simplex-2 infections when challenged three days later.